ClinicalTrials.gg
WithdrawnNCT03373513Updated Oct 16, 2024

Robotic-assisted Hysterectomy: Single- vs. Multi-port Laparoscopic Access

An interventional study of Robotic single-site Hysterectomy and Laparoscopic hysterectomy in Activity, Motor, Pain and Wound, sponsored by Herning Hospital. Withdrawn at 1 site in Denmark. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-16.

Primary conditionPainRegistry: Motor ActivityReclassifiedWhy we changed it
Registry
Motor Activity — the first condition term the registry derived for this study.
ClinicalTrials.gg
Pain
Why
  1. Motor Activity is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Pain.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Herning Hospital · Not applicable, Interventional, and Treatment

Why this study was withdrawn
hospital never sterted on single site laparoscopy
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

robotic single site surgery (R-SSH) is a novel technique, which may be superior to conventional multiport hysterectomy in select patients regarding cosmesis and postoperative pain. We, perform a randomized trial to compare R-SSH with multiport laparoscopic hysterectomy with regard to the postoperative rehabilitation, cosmesis, the operational cost, and the perioperative morbidity.

Read the detailed description

The study is scheduled to start February 2018 and compares robotic single-site hysterectomy to conventional multiport hysterectomy. Procedures are performed by an experienced two-surgeon team. Patients are randomized to either conventional multiport hysterectomy (N=62) or R-SSH (N=62). Eligibility criteria are the same as for study 1. Patient's satisfaction with body image and cosmesis is assessed at different time points pre- and postoperatively by means of validated cosmesis scales and Body Image Questionnaire. Postoperative pain and analgesia use will be registered as well as secondary outcome parameters as described above. A follow-up at 1, 3 and 6 month include evaluation of the scar and registration of port-site hernias and vaginal dehiscence or other complications. Interviews and diaries will include time of return to home and work, daily activities including sexuality The R-SSH is performed using da Vinci, Xi robotic system. One single port, diameter 2 cm is applied. Applying an additional assistant port is defined conversion of procedure The laparoscopy is performed using our standard equipment and 4 trocars, 5 mm each.

Socio-economical consequences of R-SSH versus conventional laparoscopic hysterectomy Study details in preparation

Sample size calculation was based a previous study on fast track hysterectomy, which showed a difference in return to work of 4 days. 62 women in each group is needed with standard deviation ±8 and a power of 80%. To include those not working, we calculated that with an expected visual analog pain score of 0.86 ±0.2 and 62 in each group the sample was sufficient to detect of difference of 0.1 in visual analog pain score with a power of 80%. All calculation are based on two-sided testing with alpha of 0.05.

02

Conditions studied

  • Activity, Motor
  • Pain
  • Wound

Browse trials for

Keywords

  • Return-to-work, Visual analogue pain score, Cosmesis
03

In context

Pain Reclassified

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

Browse Pain studies →

Lead sponsor

Herning Hospital is the lead sponsor of 21 studies on the registry; none are open to participants now.

Compared within Pain, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Motor Activity. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • hysterectomy on benign indication,
  • American Society of Anesthetists group 1 or 2,
  • less than 35 kg/m2
  • uterine size less than 300 g estimated by ultrasound, using Ferraris formula.

Exclusion criteria

Exclusion Criteria:

  • adhesions
  • prior extensive abdominal surgery
  • prior midline incision,
  • cutis laxa of abdomen surgery
  • endometriosis
  • more than 1 cesarean section
  • malignant disease
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Active comparator
    Robotic single-site hysterectomy

    Robotic single-site hysterectomy is performed in this arm

    Procedure: Robotic single-site Hysterectomy

  • Active comparator
    Multiport Laparoscopy

    Multiport Laparoscopic hysterectomy is performed in this other arm

    Procedure: Laparoscopic hysterectomy

Interventions

  • ProcedureRobotic single-site Hysterectomy

    Robotic assisted Periumbilical single incision hysterectomy

  • ProcedureLaparoscopic hysterectomy

    Multiport laparoscopic hysterectomy

06

What researchers measure

Primary outcomes

  1. Return-to-work

    Time from operation to return work

    Time frame: up to six months after operation or until work is resumed, whichever came first

Secondary outcomes

  1. Pain measured by subjective score

    Visual analogue pain score with a minimum of '0' up to '10' on a 10 cm continious scale

    Time frame: Visual analogue pain score first, second, third, fourth, fifth, and six months after operation

07

Study locations

1 site
  • Gynecology Dept. Herning Hospital
    Herning, 7400, Denmark
08

References and documents

Publications

  • El Hachem L, Andikyan V, Mathews S, Friedman K, Poeran J, Shieh K, Geoghegan M, Gretz HF 3rd. Robotic Single-Site and Conventional Laparoscopic Surgery in Gynecology: Clinical Outcomes and Cost Analysis of a Matched Case-Control Study. J Minim Invasive Gynecol. 2016 Jul-Aug;23(5):760-8. doi: 10.1016/j.jmig.2016.03.005. Epub 2016 Mar 15. PubMed 26992935 ↗
  • Golkar FC, Ross SB, Sperry S, Vice M, Luberice K, Donn N, Morton C, Hernandez JM, Rosemurgy AS. Patients' perceptions of laparoendoscopic single-site surgery: the cosmetic effect. Am J Surg. 2012 Nov;204(5):751-61. doi: 10.1016/j.amjsurg.2011.07.026. PubMed 23140831 ↗
  • Sandberg EM, la Chapelle CF, van den Tweel MM, Schoones JW, Jansen FW. Laparoendoscopic single-site surgery versus conventional laparoscopy for hysterectomy: a systematic review and meta-analysis. Arch Gynecol Obstet. 2017 May;295(5):1089-1103. doi: 10.1007/s00404-017-4323-y. Epub 2017 Mar 29. PubMed 28357561 ↗
  • Yeung PP Jr, Bolden CR, Westreich D, Sobolewski C. Patient preferences of cosmesis for abdominal incisions in gynecologic surgery. J Minim Invasive Gynecol. 2013 Jan-Feb;20(1):79-84. doi: 10.1016/j.jmig.2012.09.008. PubMed 23312246 ↗
  • Aarts JW, Nieboer TE, Johnson N, Tavender E, Garry R, Mol BW, Kluivers KB. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2015 Aug 12;2015(8):CD003677. doi: 10.1002/14651858.CD003677.pub5. PubMed 26264829 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided — via meeting, posters, abstracts, and publications

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03373513
Lead sponsor
Herning Hospital
Responsible party
Finn Lauszus (Research Specialist, Senoir Consultant, Assistant Professor, Herning Hospital) — Principal investigator
First posted
Dec 14, 2017
Start date
Feb 1, 2019 (estimated)
Primary completion
Jan 1, 2022 (estimated)
Completion
Dec 1, 2022 (estimated)
Last update
Oct 16, 2024

Study contacts

Finn F Lauszus, MD,PhD
principal investigator · Gynecology Department, Herning Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion